02/12/2024
🫐 Blueberry Life is now Directly Authorised by the FCA! ✅
Today marks a significant milestone in our mission to redefine life insurance for individuals with chronic health conditions.
The FCA authorisation aligns seamlessly with our ambitious growth strategy for 2025, serving as a catalyst for our broader plans to reshape the life insurance landscape. This regulatory milestone not only validates our innovative approach, but also paves the way for new offerings designed to better serve customers facing chronic health challenges.
Dr. Karan Mehta, CEO of Blueberry Life, comments:
“Securing direct authorisation from the FCA is a significant milestone for Blueberry Life. This approval not only reinforces our commitment to providing innovative and inclusive life insurance solutions but also empowers us to accelerate our mission of transforming the industry. With this foundation, we are excited to support even more customers with chronic health conditions and redefine what life insurance can achieve.”
This announcement comes as we recently unveiled our newly expanded life insurance offering, which caters to individuals with a broader range of health conditions, including Type 1 diabetes, pre-diabetes, high blood pressure, high BMI, and high cholesterol. By addressing these underserved needs, we aim to revolutionise traditional insurance models with advanced tools that empower customers to improve their health while earning rewards for their efforts. 🚀